NewsBenzingaAcurx Pharmaceuticals Says First Patient Enrolled In New PATHFINDER Clinical Trial In Patients With Multiply Recurrent C. Difficile Infection Acurx Pharmaceuticals Says First Patient Enrolled In New PATHFINDER Clinical Trial In Patients With Multiply Recurrent C. Difficile Infection Benzinga 2026.09.29 12:07 (GMT+0) Open on Benzinga Other news Meta says Muse has over 10M users, with shopping a top activity One of Your Fuel Bills Is Poised to Be Lower This Year Year-old AI lab Flapping Airplanes raises $1B at a $6B valuation Strategy: I Called The Repeg, Now The Bitcoin Machine Can Restart (NASDAQ:MSTR) Teledyne Technologies Incorporated (TDY) Q3 2026 Earnings Call Transcript Stocks Rally on Positive AI News, with SpaceX up +7%
